In 2006, Novartis dedicated US£755 million in corporate citizenship initiatives world wide, specially specializing in strengthening access to medicines in the creating world through its Usage of Medication tasks, such as donations of medicines to patients afflicted by leprosy, tuberculosis, and malaria; Glivec client help applications; and aid to support https://www.social-bookmarking.org/en/harnessing-cutting-edge-techniques-for-advanced-pharmaceutical-outcomes